Merck held talks to buy Swiss biotech MoonLake for more than $3bn
US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent
You are not logged in so some information on this page has been withheld. To see more, please log in.
MoonLake
since
auto-detected in 7 stories
2 days ago
page 1 of 1